Health Economic Evaluation Of Orally Versus Subcuteanously Administered Disease Modifying Therapies For Patients Diagnosed With Relapsing Remitting Muliple Sclerosis
May 1, 2016, 00:00
10.1016/j.jval.2016.03.222
https://www.valueinhealthjournal.com/article/S1098-3015(16)00290-4/fulltext
Title :
Health Economic Evaluation Of Orally Versus Subcuteanously Administered Disease Modifying Therapies For Patients Diagnosed With Relapsing Remitting Muliple Sclerosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00290-4&doi=10.1016/j.jval.2016.03.222
First page :
A69
Section Title :
Neurological Disorders - Health Care Use & Policy Studies
Open access? :
No
Section Order :
1570